Skip to main content
Clinical Trials/NCT01561885
NCT01561885CompletedNot Applicable

A Pragmatic Randomized Controlled Trial of Patient-Centered Integrated Clinical Pathways Based Versus Usual Care in an Academic Center: National Guard Health Affairs Western Region Experience

Majed Aljeraisy2 sites in 1 country341 target enrollmentStarted: March 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
341
Locations
2
Primary Endpoint
Decrease in length of hospital stay by two days

Study Overview

Brief Summary

The aim of this study is to determine if by providing a collaborative, integrated pathway-based healthcare compared to the usual healthcare, whether or not this would be superior in reducing the length of hospital stay across five high frequency /high risk medical diagnoses: Acute Venous Thromboembolism, Acute Kidney Injury, Community Acquired Pneumonia, Adult Left Ventricular Heart Failure, and Asthma.

Detailed Description

This study is a pragmatic randomized controlled trial. To date, there is a scarcity of randomized controlled trials looking at pathway-based, patient-centered healthcare versus usual care in several high-risk or high volume diagnoses that account for the vast majority of hospitalizations in medical settings.

In this study, the pathway care intervention is a collaborative effort that involves healthcare professionals from multiple departments, including pharmacists, health educators, nurses, social workers, nutritionists, and quality management.

For patients allocated to the usual care, these healthcare professionals will deliver standardized care when consulted. For pathway care patients, this collaborative healthcare will be default.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Single (Participant)

Eligibility Criteria

Ages
14 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Decrease in length of hospital stay by two days

Time Frame: During hospitalization period of 7 to 10 days

Secondary Outcomes

  • 30-Day Rehospitalization(After discharge up to 30 days)
  • Determinants of the Length of Stay(Upon admission until discharge)
  • Pathway Care Specific Clinical Outcomes(Upon admission until discharge)

Investigators

Sponsor
Majed Aljeraisy
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Majed Aljeraisy

Research Office Head

King Abdullah International Medical Research Center

Study Sites (2)

Loading locations...

Similar Trials

Collaborative Healthcare Professionals... | Clinical Trial